MDD is the most common form, affecting 15-20% of the population in the USA
At Condrell Primary Care, with offices in Washington, D.C., and Bethesda, MD, our medical team, led by Dr
Iron studies: a panel of serum iron, transferrin and transferrin saturation, read alongside ferritin to judge iron status
The secondary endpoint was the percentage weight loss at M3 compared to baseline
Gentle dose increases reduce the risk of retinopathy worsening Your body adjusts more comfortably to metabolic changes over time Slower improvement may delay results slightly but protects long-term vision Patience during the early weeks of treatment pays off in the months ahead Do not delay needed diabetes control, instead coordinate dosing and monitoring so improvements occur at a pace your eyes can tolerate We encourage you to pay attention to your vision between scheduled exams and report any changes promptly